Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2021-09-15
2022-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will receive an intervention including a 2-week socialization phase (control condition) and a 4-week speech breathing intervention phase (experimental condition). Both phases will be delivered remotely and in a group setting (10 participants per group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Practicing Active Breathing Exercises on Elderly Individuals Living in the Community
NCT06328192
Lifestyle Interventions for Seniors With Apnea
NCT01422863
Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea
NCT04932447
Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence
NCT02312765
The Impact of Diaphragm Training on Dysphagia in Elderly Nursing Home Residents
NCT06393283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All participants
This is a single-arm trial. All participants will receive (1) a control condition (socialization phase, 2 weeks) and (2) an intervention condition (speech breathing intervention, 4 weeks). Group sessions will take place once a week, and participants will be instructed to practice their exercises every day at home during the study duration.
Socialization phase
Control condition: does not involve speech-related exercises
Speech breathing intervention
Experimental condition: involves speech-related exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Socialization phase
Control condition: does not involve speech-related exercises
Speech breathing intervention
Experimental condition: involves speech-related exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* report dyspnea in at least one of the items of the University of Cincinnati Dyspnea Questionnaire referring to speech
* be available during the dates of the scheduled group interventions
* be aged 50 years or older
Exclusion Criteria
* present with a known voice pathology (other than age-related vocal fold atrophy) and/or are receiving speech therapy at the time of the study
* have a known neurodegenerative disease affecting speech/voice
* are a current smoker
* are receiving pulmonary rehabilitation at the time of the study or are starting a new medication regimen for a respiratory disease at the time of study onset;
* have a hearing loss that is not adequately managed, as judged by the Principal Investigator (PI)
* have professional vocal training \[amateur choir singers will not be excluded\]
* cannot provide informed consent or easily follow instructions
* have any other condition that precludes them from participating in the behavioral interventions, as judged by the PI.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maude Desjardins
Post-doctoral researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1767412
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.